Buparlisib : A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer
Igf Protein
Approximately 98% of IGF-1 is always bound to one of six binding proteins (IGF-BP)
